Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury: Biologic and clinical significance

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 2, 1998, Pages 386-394

  Vergnese, G M ^b   McCormick Shannon, K ^b   Mason, R J ^b   Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; KERATINOCYTE GROWTH FACTOR; MITOGENIC AGENT; NEUTRALIZING ANTIBODY; PROTEIN; SCATTER FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG INJURY; MALE; PRIORITY JOURNAL;

EID: 0031847251     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.2.9711111     Document Type: Article

References (61)

1. Albertine, K. 1993. Histopathology of pulmonary edema and the acute respiratory distress syndrome. M. A. Matthay and D. H. Ingbar, editors. Marcel Dekker, New York, NY. 37-83.
2. Bachofen, M., and E. Weibel. 1982. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med. 3: 35-56.
3. Bachofen, M., and E. R. Weibel. 1977. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis. 116:589-615.
4. Petty, T., G. Silvers, G. Paul, and R. Stanford. 1979. Abnormalities in lung elastic properties and surfactant function in acute respiratory distress syndrome. Chest 75:571-575.
5. Gregory, T., W. Longmore, M. Moxley, J. Whitsett, C. Reed, A. R. Fowler, L. Hudson, R. Maunder, C. Crim, and T. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976-1981.
6. Matthay, M. A., and J. P. Wiener-Kronish. 1990. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am. Rev. Respir. Dis. 142:1250-1257.
7. Witschi, H. P. 1976. Proliferation of type II alveolar cells: a review of common responses in toxic lung injury. Toxicology 5:267-277.
8. Mason, R. J., C. C. Leslie, K. McCormick-Shannon, R. R. Deterding, T. Nakamura, J. S. Rubin, and J. M. Shannon. 1994. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 11:561-567.
9. Nakamura, T., T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, and S. Shimizu. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443.
10. Panos, R. J., J. S. Rubin, S. A. Aaronsen, and R. J. Mason. 1993. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J. Clin. Invest. 92:969-977.
11. Wolf, H. K., R. Zarnegar, and G. K. Michaelopoulos. 1991. Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 14:488-494.
12. Aaronsen, S. A., D. Bottaro, T. Miki, D. Ron, P. Finch, T. Fleming, J. Ahn, W. Taylor, and J. S. Rubin. 1991. Keratinocyte growth factor: a fibroblast growth factor family member with unusual target cell specificity. Ann. N.Y. Acad. Sci. 638:62-77.
13. Rubin, J. S., A. M.-L. Chan, D. P. Bottaro, W. H. Burgess, W. G. Taylor, A. C. Cech, D. W. Hirschfield, J. Wong, T. Miki, P. W. Finch, and S. A. Aaronsen. 1991. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc. Nat. Acad. Sci. U.S.A. 88:415-419.
14. Rubin, J. S., H. Osada, P. W. Finch, W. G. Taylor, S. Rudikoff, and S. A. Aaronson. 1989. Purification and characterization of a newly identified growth factor for epithelial cells. Proc. Nat. Acad. Sci. U.S.A. 86: 802-806.
15. Nusrat, A., C. A. Parkos, A. E. Bacarra, P. J. Godowski, C. Delp-Archer, E. M. Rosen, and J. L. Madera. 1994. Hepatocyte growth factor/scatter factor effects on epithelia. J. Clin. Invest. 93:2056-2065.
16. Rubin, J. S., D. P. Bottar, M. Chedid, T. Miki, D. Ron, G. R. Cunha, and P. W. Finch. 1995. Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction. In I. D. Goldberg and E. M. Rosen, editors. Epithelial-Mesenchymal Interactions in Cancer. Birkhauser Verlag, Basel, Switzerland. 191-214.
17. Weidner, K. M., G. Hartmann, M. Sachs, and W. Birchmeier. 1993. Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. Am. J. Respir. Cell Mol. Biol. 8:229-237.
18. Werner, S., H. Smola, X. Liao, M. T. Longaker, T. Krieg, P. H. Hofschnieder, and L. T. Williams. 1994. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266: 819-822.
19. Ueda, T., Y. Takyama, S. Kishida, M. Yamamoto, and Y. Saitoh. 1996. Significant elevation of serum human hepatocyte growth factor levels in patients with acute pancreatitis. Pancreas 12:76-83.
20. Tsubouchi, H., Y. Niitani, S. Hirono, H. Nakayama, E. Gohda, N. Arakaki, O. Sakiyama, K. Takahashi, M. Kimoto, S. Kawakami, M. Setoguchi, T. Tachikawa, S. Shin, T. Arima, and Y. Daikuhara. 1991. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13:1-5.
21. Nakamura, Y., R. Morishita, S. Nakamura, M. Aoki, A. Moriguchi, K. Matsumoto, T. Nakamura, J. Higaki, and T. Ogihara. 1996. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 28:409-413.
22. Maeda, J., N. Ueki, T. Hada, and K. Higashino. 1995. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am. J. Respir. Crit. Care Med. 152:1587-1591.
23. Yanagita, K., K. Matsumoto, K. Sekiguchi, H. Ishibashi, Y. Niho, and T. Nakamura. 1993. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 268: 21212-21217.
24. Panos, R. J., P. M. Bak, W. S. Simonet, J. S. Rubin, and L. J. Smith. 1995. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J. Clin. Invest. 96:2026-2033.
25. Mason, C. M., B. P. H. Guery, W. R. Summer, and S. Nelson. 1996. Keratinocyte growth factor attenuates lung leak induced by alpha-naphthylthiourea in rats. Crit. Care Med. 24:925-931.
26. Yano, T., R. R. Deterding, W. J. Simonet, J. M. Shannon, and R. J. Mason. 1996. Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am. J. Respir. Cell Mol. Biol. 15:433-442.
27. Yi, E. S., S. T. Williams, H. Lee, D. M. Malicki, E. M. Chin, S. Yin, J. Tarpley, and T. R. Ulich. 1996. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am. J. Pathol. 149:1963-1970.
28. Deterding, R. R., A. M. Havill, T. Yano, S. C. Middleton, C. R. Jacoby, J. M. Shannon, W. S. Simonet, and R. J. Mason. 1997. Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc. Assoc. Am. Physicians 109:254-268.
29. Pittet, J., R. Mackersie, T. Martin, and M. A. Matthay. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155:1187-1205.
30. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. Legall, A. Morris, and R. Spragg. 1994. The American-European Consensus Conference on ARDS. Am. Rev. Respir. Dis. 149:818-824.
31. Matthay, M. A., W. L. Eschenbacher, and E. J. Goetzl. 1984. Elevated concentrations of leukotrienes D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome. J. Clin. Immunol. 4:479-483.
32. Berthiaume, Y., N. Staub, and M. A. Matthay. 1987. Beta-adrenergic agonists increase lung liquid clearance from the alveoli of anesthetized sheep. J. Clin. Invest. 79:335-343.
33. Berthiaume, Y., V. C. Broaddus, M. A. Gropper, T. Tanita, and M. A. Matthay. 1988. Alveolar liquid and protein clearance from normal dog lungs. J. Appl. Physiol. 65:585-593.
34. Panos, R. J., A. Suwabe, C. C. Leslie, and R. J. Mason. 1990. Hypertrophic alveolar type II cells from silica treated rats are committed to DNA synthesis in vitro. Am. J. Respir. Cell Mol. Biol. 3:51-59.
35. Dobbs, L., E. Geppert, M. Williams, R. Greenleaf, and R. Mason. 1980. Metabolic properties and ultrastructure of alveolar type II cells. Biochim. Biophys. Acta 618:510-523.
36. LeGall, J. R., S. Lemeshow, and F. Saulnier. 1993. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. J.A.M.A. 270:2957-2963.
37. Murray, J. F., M. A. Matthay, J. M. Luce, and M. R. Flick. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-723.
38. Tamura, M., N. Arakaki, H. Tsubouchi, H. Takada, and Y. Daikuhara. 1993. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J. Biol. Chem. 268:8140-8145.
39. Millar, A., N. Foley, M. Singer, M. Johnson, A. Meager, and G. Rook. 1989. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2:712-714.
40. Jacobs, R. F., D. R. Tabor, W. Burks, and G. D. Campbell. 1989. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140: 1686-1692.
41. Suter, P. M., S. Suter, E. Girardin, P. Roux-Lombard, G. E. Grau, and J.-M. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145:1016-1022.
42. Pugin, J., G. M. Verghese, M.-C. Widmer, and M. A. Matthay. 1997. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of ARDS (abstract). Am. J. Respir. Crit. Care Med. 155:A390.
43. Ohmichi, H., K. Matsumoto, and T. Nakamura. 1996. In vivo mitogenic action of HGF on lung epithelial cells: pulmotrophic role in lung regeneration. Am. J. Physiol. 270:L1031-L1039.
44. Wolf, H., R. Zarnegar, and G. K. Michalopoulos. 1991. Localization of hepatocyte growth factor in human tissues: an immunohistochemical study. Hepatology 14:488-494.
45. Yanagita, K., M. Nagaike, H. Ishibashi, Y. Niho, K. Matsumoto, and T. Nakamura. 1992. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. Biophys. Res. Commun. 182:802-809.
46. Sugahara, K., J. S. Rubin, R. J. Mason, E. L. Aronsen, and J. M. Shannon. 1995. Keratinocyte growth factor increases mRNAs for SP-A and SP-B in adult rat alveolar type II cells in culture. Am. J. Physiol. 269: L344-L350.
47. Ulich, T. R., E. S. Yi, K. Longmuir, S. Yin, R. Blitz, C. F. Morris, R. M. Housley, and G. F. Pierce. 1994. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest. 93:1098-1306.
48. Werner, S., K. G. Peters, M. T. Longaker, F. Fuller-Page, M. J. Banda, and L. T. Williams. 1992. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Nat. Acad. Sci. U.S.A. 89:6896-6900.
49. Staiano-Coica, L., J. G. Krueger, J. S. Rubin, S. D'Iimi, V. P. Vallat, L. Valentino, T. Fahey, A. Hawes, G. Kingston, M. R. Madden, et al. 1993. Human keratinocyte growth factor effects on a porcine model of epidermal wound healing. J. Exp. Med. 178:865-878.
50. Brauchle, M., K. Angermeyer, G. Hubner, and S. Werner. 1994. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 9:3199-3204.
51. Chedid, M., J. S. Rubin, K. G. Csaky, and S. A. Aaronson. 1994. Regulation of keratinocyte growth factor gene expression by interleukin-1. J. Biol. Chem. 269:10753-10757.
52. Chesnutt, A. N., F. Kheradmand, H. G. Folkesson, M. Alberts, and M. A. Matthay. 1997. Soluble transforming growth factor-alpha is present in the pulmonary edema fluid of patients with acute lung injury. Chest 111:652-656.
53. Doyle, R., N. Szlafarski, G. Modin, J. P. Weiner-Kronish, and M. A. Matthay. 1995. Identification of patients with acute lung injury: predictors of mortality. Am. J. Respir. Crit. Care Med. 152:1854-1859.
54. Chesnutt, A., M. A. Matthay, F. Tibayan, and J. Clark. 1997. Early detection of type III procollagen peptide in acute lung injury: pathogenetic and prognostic significance. Am. J. Respir. Crit. Care Med. 156: 840-845.
55. Tremblay, L., F. Valenza, S. P. Ribiero, J. F. Li, and A. S. Slutsky. 1997. Injurious ventilator strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model. J. Clin. Invest. 99:944-952.
56. Levine, B., J. Kalman, L. Mayer, H. M. Fillit, and M. Packer. 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323:236-241.
57. Torre-Amiano, G., S. Kapadia, C. Benedict, H. Oral, J. B. Young, and D. L. Mann. 1996. Proinflammatory cytokine levels in patients with depressed left ventricular function: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J. Am. Coll. Cardiol. 27:1201-1205.
58. Ferrari, R., T. Bachetti, R. Confortini, C. Opasich, O. Febo, A. Corti, G. Cassani, and O. Visioli. 1995. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92:1479-1486.
59. Hennein, H. A., H. Ebba, J. L. Rodriguez, S. H. Merrick, F. M. Keith, M. H. Bronstein, J. M. Leung, D. T. Mangano, L. J. Greenfield, and J. S. Rankin. 1994. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J. Thorac. Cardiovasc. Surg. 108:626-635.
60. Bachofen, H., M. Bachofen, and E. R. Weibel. 1988. Ultrastructural aspects of pulmonary edema. J. Thorac. Imaging 3:1-7.
61. Wang, Y., H. Folkesson, C. Jayr, and M. A. Matthay. 1998. Alveolar epithelial fluid transport can be upregulated simultaneously in vivo by two different mechanisms: alveolar type II cell proliferation (KGF) and beta-adrenergic stimulation (terbutaline) (abstract). Am. J. Respir. Crit. Care Med. 157:A848.